Cell-based Assay Market 2022-2027: Growth, Share, Size, Analysis, Outlook and Forecast

According to the latest report by IMARC Group, titled “Cell-based Assay Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, offers a comprehensive analysis of the industry, which comprises insights on the global cell-based assay market. The report also includes competitor and regional analysis, and contemporary advancements in the global market.

The global cell-based assay market size reached a value of US$ 18.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 31.4 Billion by 2027, exhibiting at a CAGR of 8.78% during 2022-2027. A cell-based assay refers to an analytical method used to determine the concentration of a substance by observing its effects on tissues or living organisms. Unlike biochemical assay, it studies intact or fixed cells instead of quantifying cell lysate. A cell-based assay is extensively utilized in subcellular localization, monitoring environmental pollutants, measuring proliferation, testing cytotoxicity, etc. In addition to this, it is also used to evaluate a vast array of biochemical, functional, and biological effects, such as gene activation, cell signaling, cell proliferation, antibody-dependent cellular cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC), apoptosis, necrosis, etc.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request Free Sample Report: https://www.imarcgroup.com/cell-based-assays-market/requestsample

Market Trends:

The growing prevalence of various chronic diseases, including diabetes, arthritis, cancer, etc., is primarily driving the cell-based assay market. Additionally, the rising utilization of this method for the production of a particular cellular product and cellular morphology is further catalyzing the market growth. Besides this, the widespread adoption of the cell-based assay for high throughput screening methods, including toxicity studies, drug screening, in vitro testing, etc., on account of the numerous technological advancements, is acting as another significant growth-inducing factor. Moreover, the introduction of 3D cell-based assays is positively influencing the global market. Apart from this, the leading manufacturers are continually engaging in R&D activities to develop safer drugs using this technique, which is anticipated to fuel the cell-based assay market over the forecasted period.

Explore Full Report with TOC & List of Figures: https://www.imarcgroup.com/cell-based-assays-market

Competitive Landscape:

By IMARC group the report has also analyzed the competitive landscape of the market with some of the top cell-based assay companies being

Some of these key players include:

  • Becton Dickinson and Company
  • GE Healthcare Biopharma (Danaher Corporation)
  • Thermo Fisher Scientific Inc.
  • Merck Group
  • Perkinelmer Inc.
  • Charles River Laboratories Inc.
  • Lonza Group Ltd.
  • Cell Signaling Technology Inc.
  • Promega Corporation
  • Cell Biolabs Inc.
  • Bio-Rad Laboratories Inc.
  • Corning Inc.
  • F. Hoffmann-La Roche AG (Roche Holding AG)

Key Market Segmentation:

Breakup by Product and Services:

  • Consumables
    • Reagents and Media
    • Cells and Cell Lines
    • Probes and Labels
  • Instruments
    • Microplates
    • Microplate Readers
    • High Throughput Screening
    • Liquid Handling Systems
    • Services
  • Software

Breakup by Technology:

  • Automated Handling
  • Flow Cytometry
  • Label-Free Detection
  • High-Throughput Screening
  • Others

Breakup by Application:

  • Drug Discovery
  • Basic Research
  • ADME Studies
  • Predictive Toxicology
  • Others

Breakup by End-User:

  • Pharmaceutical and Biotechnology Companies
  • Academic and Government Institutions
  • Contract Research Organizations
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the Report:

  • Market Performance (2016-2021)
  • Market Outlook (2022-2027)
  • COVID-19 Impact on the Market
  • Porter’s Five Forces Analysis
  • Historical, Current and Future Market Trends
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Structure of the Market
  • Value Chain Analysis
  • Comprehensive Mapping of the Competitive Landscape

TOC for the Report:

  • Preface
  • Scope and Methodology
  • Executive Summary
  • Introduction
  • Global Market
  • SWOT Analysis
  • Value Chain Analysis
  • Price Analysis
  • Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Leave a Comment